Abstract: A nasal dilator, having a spring force that can be activated after the dilator is applied to the nose, is described. The nasal dilator has a spring force component and an adhesive component, which together act to dilate nasal tissues to help open or keep open the nasal valve to alleviate snoring and other breathing-related disorders.

Abstract: A delivery system and method for delivering soluble dietary fibers in a chewable tablet form which is palatable and demonstrates a high degree of consumer acceptability.

Abstract: Dilator dispensers and mounting apparatus and methods of dispensing and mounting nasal dilators to enable dilation to external tissue are provided. An apparatus may be used with a variety of types and sizes of dilator devices, including traditional elongate dilator devices for humans and animals such as horses, dogs and the like. A compact, portable, protective dilator dispenser is provided so that a user may readily access and apply a dilator device at any time. A combined apparatus including a dilator dispenser and a mounting aid is provided for a dilator device so that a dilator device may be quickly, easily and accurately applied by a user.

Abstract: A delivery system and method for delivering soluble dietary fibers in a chewable tablet form which is palatable and demonstrates a high degree of consumer acceptability.

Abstract: A delivery system and method for delivering soluble dietary fibers in a chewable tablet form which is palatable and demonstrates a high degree of consumer acceptability.

Abstract: A delivery system and method for delivering soluble dietary fibers in a chewable tablet form which is palatable and demonstrates a high degree of consumer acceptability.

Abstract: An orally administered composition for relieving or eliminating snoring is described. The composition generally has four mechanisms of action for combating snoring. The composition includes a tissue-firming or astringent agent to firm up throat tissue. The composition also includes a soothing agent to soothe irritated or inflamed tissues. Also included in the composition is a lubricant to moisten dry or dehydrated tissues, and a mucous-thinning or expectorant agent to help remove any obstructive matter near the throat tissues.

Abstract: Nasal dilators and strips, methods of their manufacture, and methods for improving the breathing of individuals are provided. The strips and dilators include an elongated substrate, with or without a dilating component or portion, having top and bottom surfaces and a pressure-sensitive adhesive disposed on the bottom surface. The dilator is designed to provide a gentle expanding force to the nasal wall tissue when the dilator is adhesively attached to the nose. This invention further includes a cosmetic fragrance, an aromatic medication and/or transdermal medication disposed on the strips or dilators. In order to improve the shelf-life and in-use olfactory effectiveness of such products, fragrance delivery mechanisms are used. Separation of volatile oils and adhesives are also provided to minimize adhesive residue.

Abstract: The invention is directed to devices and methods for tissue dilators. The present invention encompasses a large variety of discrete structure, all intended to be applied externally to a subject for the purpose of dilating, or lifting, tissue adjacent to nasal passageways of the subject, including the vestibule and/or the valve of the subject so as to decrease resistance to inhalation and exhalation of said subject during respiration. The dilator comprises an alignment feature which is aligned with the uses nasal ridge during application to ensure a proper application.

Abstract: Nasal dilators and strips, methods of their manufacture, and methods for improving the breathing of individuals are provided. The strips and dilators include an elongated substrate, with or without a dilating component or portion, having top and bottom surfaces and a pressure-sensitive adhesive disposed on the bottom surface. The dilator is designed to provide a gentle expanding force to the nasal wall tissue when the dilator is adhesively attached to the nose. This invention further includes a cosmetic fragrance, an aromatic medication and/or transdermal medication disposed on the strips or dilators. In order to improve the shelf-life and in-use olfactory effectiveness of such products, fragrance delivery mechanisms are used. Separation of volatile oils and adhesives are also provided to minimize adhesive residue.

Abstract: A nasal dilator for dilating a first nasal passage and a second nasal passage of a nose, including an elastic element having a first end and a second end, the elastic element movable toward an expanded configuration wherein the length of the elastic element increases, and biases to a retracted configuration wherein the length of the elastic element is reduced. The nasal dilator further includes an adhesive carried proximate the first end for attaching the first end to an outer wall of the first nasal passage, and an adhesive carried proximate the second end for attaching the second end to an outer wall of the second nasal passage.

Abstract: A nasal dilator for dilating a first nasal passage and a second nasal passage of a nose, including an elastic element having a first end and a second end, the elastic element movable toward an expanded configuration wherein the length of the elastic element increases, and biases to a retracted configuration wherein the length of the elastic element is reduced. The nasal dilator further includes an adhesive carried proximate the first end for attaching the first end to an outer wall of the first nasal passage, and an adhesive carried proximate the second end for attaching the second end to an outer wall of the second nasal passage.

Abstract: A volume change sensor having an elongated tubular enclosure with a thin deformable wall having a conduit for connection to a pressure monitor, there being an elongated insert material within the tubular enclosure that is wider than it is thick at some locations formed from resiliently deformable open cell foam. An elastic belt against which the tubular enclosure is positioned is used to wrap it about a respirating subject undergoing corresponding changes to measure same.

Abstract: A method and apparatus for obtaining an indication of the extent and duration of reduced power in electroencephalographic signals as a basis for determining whether blood flow to the human brain providing such signals needs to be increased.

Abstract: A system for measuring changes in the number of maxima and minima occurring in a signal over time which changes indicate activity changes in a subject from which the signal measured is obtained.

Abstract: Such representations may include the average frequency value of electroencephalographic signals, the logarithm of the power of electromyographic signals, and eye movement indications from electrooculographic signals. Criteria for dividing the records of such representations in the system into stages of sleep can be set by a system operator reviewing these records based on accepted stage definition rules. In addition, transient events such as sleep spindles, etc., in these records can be selected therefrom by criteria set by the system operator also based on accepted rules therefor.

Abstract: An electroencephalograph (EEG) signal analyzer allows the examination of the changes in EEG cerebral activity at various sites in response to an event (e.g. a stimulus or task). The analyzer includes one or more signal processing modules which periodically sample the EEG signal from each of the sites, convert the sampled signals to digital sample values, and store those values. Digitized waveforms based on the stored digital sample values and having a length equal to or greater than the period of the lowest frequency of interest are transformed from the time to the frequency domain. For each of a plurality of epochs, a frequency spectrum is produced having frequency content which has a content uniquely due to the digital sample values from that epoch. A weighted means frequency value for each site during each epoch is derived from the corresponding frequency spectrum.

Abstract: An electroencephelograph (EEG) signal analysis system automatically determines and displays, on a real-time basis, the frequency content of spontaneous EEG signals from the brain. The analog EEG signals from a plurality of channels are sampled and converted to digitized EEG waveforms during a continuing sequence of epochs of predetermined time duration. The digitized EEG waveform for each epoch and channel is transformed from the time domain to the frequency domain to produce a frequency spectrum representing amplitude of the EEG signal as a function of frequency. The digital data is screened both prior and subsequent to the transformation to identify those epochs which contain artifacts. During each update period, the frequency spectra for each channel from the artifact-free epochs are averaged. The amplitudes of each averaged frequency spectrum for frequencies in each of four basic frequency bands are then summed. The result is an amplitude value for each of the four frequency bands at each channel.